HUE032121T2 - Készítmények különbözõ eredetû perifériás fekélyek kezelésére - Google Patents

Készítmények különbözõ eredetû perifériás fekélyek kezelésére Download PDF

Info

Publication number
HUE032121T2
HUE032121T2 HUE11781765A HUE11781765A HUE032121T2 HU E032121 T2 HUE032121 T2 HU E032121T2 HU E11781765 A HUE11781765 A HU E11781765A HU E11781765 A HUE11781765 A HU E11781765A HU E032121 T2 HUE032121 T2 HU E032121T2
Authority
HU
Hungary
Prior art keywords
compositions
atok
extract
echinacea
ulcers
Prior art date
Application number
HUE11781765A
Other languages
English (en)
Inventor
Ezio Bombardelli
Paolo Morazzoni
Massimo Ronchi
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43738126&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE032121(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena Spa filed Critical Indena Spa
Publication of HUE032121T2 publication Critical patent/HUE032121T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Claims (2)

  1. fekélyek kezelésére Skahsmalmi ígé?\> pántok E KEvEtmAsyd·,. &amp;·η$:Κ·>5*. aktiv Kiavcícvbkims E \> η λ ui pohf<*K K kot \ag\' aî»î'V>AtWKk'k<; kv", oíEaí unabuaío toon.uobAî e·* b· EcMnecee f&amp;ffeól .'süâraî&amp;id hvoaa&amp;k tóöobkm cmktü perltet tekéik észtéi Upe»*»«*™**«***”* «rnazásra M-m ;. igößypon«. tóm &amp;** a«**™, ahoi a mm&amp;r «uliîeni>fek«ri3ït;ibn;sxé kjvoüSKik /φρ^κ*?*«·*5 V8*F 1 ί5ίϊ vm;?mí ^'^-kæo
  2. 3. As !. ígcaypoat «ariati krâ*fcr»è»y*fc a» c>« «;<#«tàro*>u Mmeà™, ;xbol as iastabswè y^aî;ôfe:.àKÉM^ï^>is!¥m»Â À: m %é^L;*a«m*l· M$M&amp;wk:W itt?®«, ·*Μ m- rnmím hippo; tiMümvn kivixi-na k««g: áe:;;k d manMià Ekohok* *!VOsaU: K A 2. Zypern vo Timi kEvEmmnyek *t:ou^ghaür^uu Mm^m Ä1 a *ïrA vPn/«« km-a«* ij A 3. igéîüvpofit xisrißts kësxku'.éijyitk &amp;<·: oit îaç^'b^^F-u'EK mxdiK*i4*vös. «δθ; <*·* ?.?<;<··< ·.·;<<:·-\Κο>χ8 à.. aîgîàîÉifc: K mœrtKwpon,. K aïjwtccax K &amp;yihm!.n>i'!im 'fYE > ·ΛΚ nx-atpum .vtvosms. 7. A.í: L igényem uenub k<Ksimmny<* ^ <>b meghatározol aikahnæeÀsrg, ahoi as £diinaeea kg jki vonata Ecfttwcra eagmafoíu vag y purpurén aibohmösfeLoa;mu 8\1 ,ηρο'ΐ .îl3 î U'WiV^U ttí.x'JtóoK'íx . Abvoii K',< < âH,/ A K a kővetkaK'j sràzsldms dOormbiyokkan t;mah?ta.ï.zih: ;si ka?€i'hiïS"[X>Étiîs>>l<sk vagy s:XiX.;m;vSxk:k v«gy onom't samsknaxO k s vonatok: b-umiÉ «. Y* EEiXmxou by kivooa«: CgOI · Ly-> il Ai::«ff KYghatiyKm a* aksiv öspmsvälmt a : gpvçîkfc'iui voKakkov üsiO'ííno.ítyüí'baí: larisihias:*^ ai äiölechl«']UiFE.'.«'>!oii. vagy aatoc i&amp;0"xx{tek vagy osaheîi&amp;ttaksssd klsoustôtc: EAvíhy, ps Echmez&amp;s taj kivoaaïa: KOMkiEi. |y ,-W duA» inon\pv'íiíok b:\ntK IvîV ä ^ ok >»* ou meghaiÁsv-xi xïkémeâm^iegMlh· vaey «iaxtèmàs beadásra. H X \» te*. ' * ' to\ K* \Kt V N <«*»* ä ' <' ok 'u k \ ' X mgb l»»<» « askalmâ^issa, aboi a ibkàtv ikâbôicsxa^ fekély, a vcgfsg0|£ yéaàa pang»5» mO-ftö tekéiy« vugy k:HekViîy,
HUE11781765A 2010-10-28 2011-10-21 Készítmények különbözõ eredetû perifériás fekélyek kezelésére HUE032121T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2010A002009A IT1402749B1 (it) 2010-10-28 2010-10-28 Composizioni per il trattamento di ulcere periferiche di varia origine

Publications (1)

Publication Number Publication Date
HUE032121T2 true HUE032121T2 (hu) 2017-08-28

Family

ID=43738126

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE11781765A HUE032121T2 (hu) 2010-10-28 2011-10-21 Készítmények különbözõ eredetû perifériás fekélyek kezelésére

Country Status (21)

Country Link
US (1) US9770475B2 (hu)
EP (1) EP2632475B1 (hu)
JP (1) JP6060084B2 (hu)
KR (1) KR101861347B1 (hu)
CN (1) CN103189066A (hu)
AR (1) AR083594A1 (hu)
AU (1) AU2011322734B2 (hu)
BR (1) BR112013010325A2 (hu)
CA (1) CA2816185C (hu)
DK (1) DK2632475T3 (hu)
ES (1) ES2606141T3 (hu)
HU (1) HUE032121T2 (hu)
IL (1) IL225939A (hu)
IT (1) IT1402749B1 (hu)
MX (1) MX341300B (hu)
PL (1) PL2632475T3 (hu)
PT (1) PT2632475T (hu)
RU (1) RU2606851C2 (hu)
SG (1) SG189536A1 (hu)
SI (1) SI2632475T1 (hu)
WO (1) WO2012055774A1 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016020855A1 (en) * 2014-08-08 2016-02-11 Rottapharm Biotech S.R.L. Purified grape seeds extracts, production and use thereof for the treatment of central and peripheric human diseases
KR101649450B1 (ko) * 2015-08-19 2016-08-18 이상철 피부 상처 치료조성물
ITUB20160058A1 (it) * 2016-01-19 2017-07-19 Farm S R L C U S Composizione di un preparato per il trattamento delle punture di insetto con attivita’ vasocostrittiva, lenitiva, disinfiammante e disarrossante
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
CN109121393B (zh) * 2017-02-24 2021-11-30 拉芳家化股份有限公司 一种抗炎乳液
RU2704976C2 (ru) * 2017-05-10 2019-11-01 Общество с ограниченной ответственностью "Трейдсервис" Флеботропная комбинированная фармацевтическая композиция
JP7286131B2 (ja) * 2018-11-15 2023-06-05 学校法人順天堂 糖尿病性潰瘍の治癒促進剤
JP6749383B2 (ja) * 2018-11-20 2020-09-02 丸善製薬株式会社 Ｔｉｅ２活性化剤及び血管の成熟化剤、並びにＴｉｅ２活性化用経口組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1288257B1 (it) * 1996-11-29 1998-09-11 Paoli Ambrosi Gianfranco De Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico
US20020127256A1 (en) * 2001-03-01 2002-09-12 Howard Murad Compositions and methods for treating dermatological disorders
ITMI20042414A1 (it) 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
US7303772B2 (en) * 2005-11-10 2007-12-04 Olalde Rangel Jose Angel Synergistic phytoceutical compositions
WO2007143631A2 (en) * 2006-06-02 2007-12-13 Interhealth Nutraceuticals, Inc. Nutraceutical treatments for diabetic and non-diabetic wound healing
EP1882473A1 (en) 2006-07-28 2008-01-30 Indena S.P.A. Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs
JP2008266215A (ja) * 2007-04-20 2008-11-06 Suntory Ltd 虚血後血管新生促進剤および血流改善剤
EP2344173A1 (en) * 2008-10-21 2011-07-20 Naturveda New synergic association for the treatment of deep skin or mucosa injuries
EP2179739A1 (en) 2008-10-23 2010-04-28 Matteo Tutino Compositions comprising vitamins

Also Published As

Publication number Publication date
RU2606851C2 (ru) 2017-01-10
US9770475B2 (en) 2017-09-26
DK2632475T3 (da) 2017-01-02
AU2011322734B2 (en) 2015-05-14
IL225939A (en) 2017-06-29
US20130236575A1 (en) 2013-09-12
SI2632475T1 (sl) 2016-11-30
AU2011322734A1 (en) 2013-04-18
ITMI20102009A1 (it) 2012-04-29
KR101861347B1 (ko) 2018-05-28
ES2606141T3 (es) 2017-03-22
PT2632475T (pt) 2016-12-09
MX2013004740A (es) 2013-06-05
IT1402749B1 (it) 2013-09-18
CA2816185A1 (en) 2012-05-03
AR083594A1 (es) 2013-03-06
EP2632475B1 (en) 2016-09-14
JP2013540788A (ja) 2013-11-07
KR20140000231A (ko) 2014-01-02
WO2012055774A1 (en) 2012-05-03
MX341300B (es) 2016-08-11
JP6060084B2 (ja) 2017-01-11
EP2632475A1 (en) 2013-09-04
BR112013010325A2 (pt) 2016-09-20
PL2632475T3 (pl) 2017-06-30
IL225939A0 (en) 2013-06-27
SG189536A1 (en) 2013-05-31
RU2013124384A (ru) 2014-12-10
CA2816185C (en) 2020-05-12
CN103189066A (zh) 2013-07-03

Similar Documents

Publication Publication Date Title
HUE032121T2 (hu) Készítmények különbözõ eredetû perifériás fekélyek kezelésére
Tümen et al. Research on the antioxidant, wound healing, and anti-inflammatory activities and the phytochemical composition of maritime pine (Pinus pinaster Ait)
Araújo et al. In vivo wound healing effects of Symphytum officinale L. leaves extract in different topical formulations
Puri et al. Fagonia: a potential medicinal desert plant
KR101089779B1 (ko) 정제봉독, 단풍나무 추출물 및 작살나무 추출물을 유효성분으로 포함하는 기능성 천연 화장료 조성물
Al-Snafi Arabian medicinal plants with dermatological effects-plant based review (part 1)
Ananthi et al. Screening of Invitro anti-inflammatory activity of michelia champaca linn. flowers
JP6026540B2 (ja) 種々の原因の末梢性潰瘍の治療用組成物
Anlas et al. In vitro biological activities and preliminary phytochemical screening of different extracts from Achillea sintenisii Hub-Mor
KR102475898B1 (ko) 그라비올라 항균 추출물을 함유하는 화장료 조성물 및 그 제조방법
Melnyk et al. Skowro nska, W.; Bazylko, A.; Piwowarski, JP; Granica, S. Current knowledge on interactions of plant materials traditionally used in skin diseases in Poland and Ukraine with human skin microbiota
KR20170065187A (ko) 티트리 잎 복합 추출물을 함유하는 여드름 개선용 화장료 조성물
Hayati et al. Antioxidant and Wound Healing Potential of Persea Americana Mill. Leaves extract
KR20140145268A (ko) 모공 수렴 및 여드름 균 억제 기능을 갖는 화합물이 포함된 화장료 조성물
Gupta et al. Nutraceuticals in Periodontal Health and Diseases in Dogs and Cats
Zohreh et al. Medicinal herbs effective on the skin
de Oliveira et al. Skin Phytotherapy and Pharmacological Aspects: a Brief Review
ITUA20164041A1 (it) Estratti di rami di Sambucus nigra L., procedimento per la loro produzione e loro impieghi
RU2589257C1 (ru) Зверкалипт
RO121726B1 (ro) Gel protector, pentru mucoasa nazală şi epiteliul urechii, şi procedeu de obţinere a acestuia
Tümen et al. Pine (Pinus pinaster Ait), Journal of Ethnopharmacology
Bronkhorst The antioxidant activity and cellular effects of the bioactive components of Flavonix® Cytoflamm Gel used in wound treatment
Lettner DIPLOMARBEIT/DIPLOMA THESIS
ITRM20120174A1 (it) Nuove composizioni per il trattamento delle ferite croniche.
Tokuhara Cytotoxicity of Qualea grandiflora Mart. leaf extract (Vochysiaceae) on pre-osteoblast culture. Evaluation of cell viability and expression/activity of MMPs